Etodolac Tablet, Film Coated, Extended Release
Product Images NDC 71205-140

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Etodolac (NDC 71205-140). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

00093112201

FDA Label Image

Chemical Structure For Etodolac (Etodolac Tablet Film Coated Extended Release A0756 1)

FDA Label Image

71205-140-30 (Etodolac Tablet Film Coated Extended Release A0756 2)

71205-140-30 (Etodolac Tablet Film Coated Extended Release A0756 2)
This is a description of a medication called Etodolac 400mg, which comes in 30 extended-release tablets. It is manufactured in Israel by Teva Pharmaceutical Industries and packaged by Proficient Rx LP. It can only be obtained with a prescription and the patient should be given a separate medication guide. The tablets are orange, oval, film-coated, and inscribed with "1122" on one side and "93" on the other. It's recommended to store them at 20°C to 25°C (68°F to 77°F) and keep out of children's reach. There is a lot and expiration date which is "Lot #:00000 Exp:00/00/00." The product ID is QE014030, and the National Drug Code is 71205-140-30.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.